Provider Perspectives on Factors Affecting the PrEP Care Continuum Among Black Cisgender Women in the Midwest United States: Applying the Consolidated Framework for Implementation Research.
Journal
Journal of acquired immune deficiency syndromes (1999)
ISSN: 1944-7884
Titre abrégé: J Acquir Immune Defic Syndr
Pays: United States
ID NLM: 100892005
Informations de publication
Date de publication:
01 07 2022
01 07 2022
Historique:
entrez:
15
6
2022
pubmed:
16
6
2022
medline:
18
6
2022
Statut:
ppublish
Résumé
To End the HIV Epidemic and reduce the number of incident HIV infections in the United States by 90%, pre-exposure prophylaxis (PrEP) uptake and persistence among cisgender women, particularly racial and ethnic minority women, must be increased. Medical providers play a pivotal role across the PrEP care continuum. In this qualitative study, guided by the Consolidated Framework for Implementation Research, we explored health care provider perspectives on facilitators and barriers to PrEP implementation strategies for Black cisgender women in the Midwest United States. Data were analyzed using a deductive thematic content analysis approach. A total of 10 medical providers completed individual qualitative interviews. Using the Consolidated Framework for Implementation Research framework, we identified intervention characteristics (cost, dosing, and adherence), individual patient and provider level factors (self-efficacy, knowledge, and attitudes), and systematic barriers (inner setting and outer setting) that ultimately lead to PrEP inequalities. Implementation strategies to improve the PrEP care continuum identified include provider training, electronic medical record optimization, routine patient education, and PrEP navigation. This study provides (1) medical provider insight into implementation factors that can be modified to improve the PrEP care continuum for Black cisgender women and (2) an implementation research logic model to guide future studies.
Sections du résumé
BACKGROUND
To End the HIV Epidemic and reduce the number of incident HIV infections in the United States by 90%, pre-exposure prophylaxis (PrEP) uptake and persistence among cisgender women, particularly racial and ethnic minority women, must be increased. Medical providers play a pivotal role across the PrEP care continuum.
METHODS
In this qualitative study, guided by the Consolidated Framework for Implementation Research, we explored health care provider perspectives on facilitators and barriers to PrEP implementation strategies for Black cisgender women in the Midwest United States. Data were analyzed using a deductive thematic content analysis approach.
RESULTS
A total of 10 medical providers completed individual qualitative interviews. Using the Consolidated Framework for Implementation Research framework, we identified intervention characteristics (cost, dosing, and adherence), individual patient and provider level factors (self-efficacy, knowledge, and attitudes), and systematic barriers (inner setting and outer setting) that ultimately lead to PrEP inequalities. Implementation strategies to improve the PrEP care continuum identified include provider training, electronic medical record optimization, routine patient education, and PrEP navigation.
CONCLUSION
This study provides (1) medical provider insight into implementation factors that can be modified to improve the PrEP care continuum for Black cisgender women and (2) an implementation research logic model to guide future studies.
Identifiants
pubmed: 35703766
doi: 10.1097/QAI.0000000000002974
pii: 00126334-202206001-00018
pmc: PMC9204843
mid: NIHMS1791052
doi:
Substances chimiques
Anti-HIV Agents
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
S141-S148Subventions
Organisme : NIAID NIH HHS
ID : P30 AI117943
Pays : United States
Informations de copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to disclose.
Références
Control CfD, Prevention. Diagnoses of HIV infection in the United States and dependent areas, 2019. Vol. 32. 2019. HIV Surveillance Report. Available at: http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html . Published May 2021.
Sullivan PS, Woodyatt C, Koski C, et al. A data visualization and dissemination resource to support HIV prevention and care at the local level: analysis and uses of the AIDSVu public data resource. J Med Internet Res. 2020;22:e23173.
Denning P, DiNenno E. Communities in crisis: is there a generalized HIV epidemic in impoverished urban areas of the United States. Proceedings from XVIII International AIDS Conference, Vienna, Austria; 2010.
Smith DK, Van Handel M, Grey J. Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race/ethnicity, United States, 2015. Ann Epidemiol. 2018;28:850–857.
Hirschhorn LBR, Friedman E, Christeller C, et al. Women's PrEP Knowledge, attitudes, preferences, and experience in Chicago. Presented at: 2019 Conference on Retroviruses and Opportunistic Infections, 2019, Seattle, WA.
Siegler A, Mouhanna F, Giler RM, et al. The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States. Ann Epidemiol. 2018;28:841–849.
HIV Surveillance Report, 2017 (Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC). Washington, DC: U.S. Department of Health and Human Services; 2018.
Fauci AS, Redfield RR, Sigounas G, et al. Ending the HIV epidemic: a plan for the United States. JAMA. 2019;321:844–845.
St Vil NM, Przybyla S, LaValley S. Barriers and facilitators to initiating PrEP conversations: perspectives and experiences of health care providers. J HIV/AIDS Soc Serv. 2019;18:166–179.
Pleuhs B, Quinn KG, Walsh JL, et al. Health c1are provider barriers to HIV pre-exposure prophylaxis in the United States: a systematic review. AIDS Patient Care STDs. 2020;34:111–123.
Calabrese SK, Tekeste M, Mayer KH, et al. Considering stigma in the provision of HIV pre-exposure prophylaxis: reflections from current prescribers. AIDS Patient Care STDs. 2019;33:79–88.
Nunn AS, Brinkley-Rubinstein L, Oldenburg CE, et al. Defining the HIV pre-exposure prophylaxis care continuum. AIDS. 2017;31:731.
Pyra M, Johnson AK, Devlin S, et al. HIV pre-exposure prophylaxis use and persistence among Black Ciswomen:“Women need to protect themselves, period”. J Racial Ethnic Health Disparities. 2021:1–10.
Agovi AMA, Anikpo I, Cvitanovich MJ, et al. Knowledge needs for implementing HIV pre-exposure prophylaxis among primary care providers in a safety-net health system. Prev Med Rep. 2020;20:101266.
Calabrese SK, Magnus M, Mayer KH, et al. Putting PrEP into practice: lessons learned from early-adopting U.S. Providers' firsthand experiences providing HIV pre-exposure prophylaxis and associated care. PLoS One. 2016;11:e0157324.
Mayer KH, Agwu A, Malebranche D. Barriers to the wider use of pre-exposure prophylaxis in the United Statess: a narrative review. Adv Ther. 2020;37:1778–1811.
Arnold EA, Hazelton P, Lane T, et al. A qualitative study of provider thoughts on implementing pre-exposure prophylaxis (PrEP) in clinical settings to prevent HIV infection. PLoS One. 2012;7:e40603.
Kimmel AL, Messersmith LJ, Bazzi AR, et al. Implementation of HIV pre-exposure prophylaxis for women of color: perspectives from healthcare providers and staff from three clinical settings. J HIV/AIDS Soc Serv. 2020;19:299–319.
Jackson-Gibson M, Ezema AU, Orero W, et al. Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya. BMC Public Health. 2021;21:1–13.
Damschroder LJ, Aron DC, Keith RE, et al. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:1–15.
Safaeinili N, Brown‐Johnson C, Shaw JG, et al. CFIR simplified: pragmatic application of and adaptations to the Consolidated Framework for Implementation Research (CFIR) for evaluation of a patient‐centered care transformation within a learning health system. Learn Health Syst. 2020;4:e10201.
Coleman C, Sales J, Escoffery C, et al. Primary care and pre-exposure prophylaxis services in publicly funded family planning clinics in the southern United States. J Gen Intern Med. 2021;36:2958–2965.
Sales JM, Escoffery C, Hussen SA, et al. Pre-exposure prophylaxis implementation in family planning services across the southern United States: findings from a survey among staff, providers and administrators working in title X-funded clinics. AIDS Behav. 2021;25:1901–1912.
Bernard HR. Qualitative data analysis I: text analysis. Res Methods Anthropol. 2002:440–448.
Padgett DK. Qualitative and Mixed Methods in Public Health: Thousand Oaks, CA: Sage publications; 2011.
Dedoose Version 8.0.35, Web Application for Managing, Analyzing, and Presenting Qualitative and Mixed Method Research Data. Available at: www.dedoose.com . Accessed June, 2021.
Hirschhorn LR, Brown RN, Friedman EE, et al. Black cisgender women's PrEP knowledge, attitudes, preferences, and experience in Chicago. J Acquir Immune Defic Syndr. 2020;84:497–507.
Laborde ND, Kinley PM, Spinelli M, et al. Understanding PrEP persistence: provider and patient perspectives. AIDS Behav. 2020;24:2509–2519.
Calabrese SK, Earnshaw VA, Underhill K, et al. The impact of patient race on clinical decisions related to prescribing HIV pre-exposure prophylaxis (PrEP): assumptions about sexual risk compensation and implications for access. AIDS Behav. 2014;18:226–240.
Hull SJ, Tessema H, Thuku J, et al. Providers PrEP: identifying primary health care providers' biases as barriers to provision of equitable PrEP services. JAIDS. 2021;88:165–172.
Przybyla S, LaValley S, St Vil N. Health care provider perspectives on pre-exposure prophylaxis: a qualitative study. J Assoc Nurses AIDS Care. 2019;30:630–638.
Siegler AJ, Mouhanna F, Giler RM, et al. The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States. Ann Epidemiol. 2018;28:841–849.
Calabrese SK, Krakower DS, Mayer KH. Integrating HIV preexposure prophylaxis (PrEP) into routine preventive health care to avoid exacerbating disparities. Am J Public Health. 2017;107:1883–1889.
Seale C, Silverman D. Ensuring rigour in qualitative research. Eur J Public Health. 1997;7:379–384.